Desvenlafaxine succinate: A new serotonin and norepinephrine reuptake inhibitor

Journal of Pharmacology and Experimental Therapeutics

Volumn 318, Issue 2, 2006, Pages 657-665

  Deecher, Darlene C ^a   Beyer, Chad E ^a   Johnston, Grace ^a   Bray, Jenifer ^a   Shah, S ^b   Abou Gharbia, M ^c   Andree, Terrance H ^a  

^a PFIZER INC   (United States)

^b WYETH RESEARCH   (United States)

^c Chemical and Screening Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPIN 2 ONE DERIVATIVE; CANNABINOID; CHOLECYSTOKININ; DESIPRAMINE; DESVENLAFAXINE; DOPAMINE TRANSPORTER; ESTROGEN; FLUOXETINE; GALANIN; GLUCOCORTICOID; GLUTAMIC ACID; HISTAMINE; IMIDAZOLINE; ION CHANNEL; MAZINDOL; MELATONIN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NICOTINIC ACID; NORADRENALIN; NORADRENALIN TRANSPORTER; NORADRENALIN UPTAKE INHIBITOR; PROGESTERONE; RADIOLIGAND; SEROTONIN; SEROTONIN 1A ANTAGONIST; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; SODIUM CHLORIDE; TESTOSTERONE; VENLAFAXINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; HYPOTHALAMUS; IN VITRO STUDY; IN VIVO STUDY; MALE; MEMBRANE BINDING; NONHUMAN; NORADRENALIN BLOOD LEVEL; PRIORITY JOURNAL; RAT;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BRAIN; BRAIN CHEMISTRY; CELL LINE; CELL MEMBRANE; CYCLOHEXANOLS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HUMANS; HYPOTHALAMUS; MALE; MICRODIALYSIS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; PROTEIN BINDING; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS;

EID: 33745958408     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.103382     Document Type: Article

References (34)

1. Amara SG and Kuhar MJ (1993) Neurotransmitter transporters: recent progress. Annu Rev Neurosci 16:73-93.
2. Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, and Goldstein DJ (2004) A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 50:2974-2984.
3. Beyer CE, Boikess S, Luo B, and Dawson LA (2002) Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study. J Psychopharmacol 16:297-304.
4. Blakely RD and Bauman AL (2000) Biogenic amine transporters: regulation in flux. Curr Opin Neurobiol 10:328-336.
5. Bymaster FP, Dreshfield-Ahmad LJ, Threlkeld PG, Shaw JL, Thompson L, Nelson DL, Hemrick-Luecke SK, and Wong DT (2001) Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes and other neuronal receptors. Neuropsychopharmacology 25:871-880.
6. Chaput Y, de Montigny C, and Blier P (1986) Effects of a selective 5-HT reuptake blocker, citalopram, on the sensitivity of 5-HT autoreceptors: electrophysiological studies in the rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 333:342-348.
7. 50) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
8. Fraser MO and Chancellor MB (2003) Neural control of the urethra and development of pharmacotherapy for stress urinary incontinence. BJU Int 91:743-748.
9. Goldstein DJ, Lu Y, Detke MJ, Lee TC, and Iyengar S (2005) Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 116:109-118.
10. Iyengar S, Webster AA, Hemrick-Luecke SK, Xu JY, and Simmons RMA (2004) Efficacy of duloxetine, a Potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats. J Pharmacol Exp Ther 311:576-584.
11. 1A receptors in rats treated chronically with a novel antidepressant, cericlamine. J Pharmacol Exp Ther 268:1432-1443.
12. Kaneko YS, Mori K, Nakashima A, Sawada M, Nagatsu I, and Ota A (2005) Peripheral injection of lipopolysaccharide enhances expression of inflammatory cytokines in murine locus coeruleus: possible role of increased norepinephrine turnover. J Neurochem 94:393-404.
13. Kirwin JL and Goren JL (2005) Duloxetine: a dual serotonin-norepinephrine reuptake inhibitor for treatment of major depressive disorder. Pharmacotherapy 25:396-410.
14. Kreiss DS and Lucki I (1995) Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. J Pharmacol Exp Ther 274:866-876.
15. Ladd CO, Newport DJ, Ragan KA, Loughhead A, and Stowe ZN (2005) Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depression. Depress Anxiety 22:94-97.
16. 1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology 39:110-122.
17. 1A autoreceptors in rats treated with fluoxetine or paroxetine. Naunyn-Schmiedeberg's Arch Pharmacol 352:141-148.
18. Maleki N, Nayebi AM, and Garjani A (2005) Effects of central and peripheral depletion of serotonergic system on carrageenan-induced paw oedema. Int Immunopharmacol 5:1723-1730.
19. Mariappan P, Ballantyne Z, N' Dow JM, and Alhasso AA (2005) Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults, in The Cochrane Database of Systematic Reviews: Reviews 2005, issue 3, John Wiley & Sons, Ltd., Chichester, UK.
20. Muth EA, Haskins JT, Moyer JA, Husbands GE, Nielsen ST, and Sigg EB (1986) Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative. Biochem Pharmacol 35:4493-4497.
21. Owens MJ, Morgan WN, Plott SJ, and Nemeroff CB (1997) Neurotransmitter receptor and transporter binding profile of antidepressants and their metabolites. J Pharmacol Exp Ther 283:1305-1322.
22. Pacholczyk T, Blakely RD, and Amara SG (1991) Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature (Lond) 350:350-354.
23. Paxinos G (1986) The Rat Brain in Stereotaxic Coordinates, Academic Press, New York.
24. Prasad PD, Hoffmans BJ, Moe AJ, Smith CH, Leibach FH, and Ganapathy V (1996) Functional expression of the plasma membrane serotonin transporter but not the vesicular monoamine transporter in human placental trophoblasts and choriocarcinoma cells. Placenta 17:201-207.
25. 3H]GBR 12,935 binding. Mol Pharmacol 45: 125-135.
26. Ramamoorthy JD, Ramamoorthy S, Papapetropoulos A, Catravas JD, Leibach FH, and Ganapathy V (1995) Cyclic AMP-independent up-regulation of the human serotonin transporter by staurosporine in choriocarcinoma cells. J Biol Chem 270:17189-17195.
27. Sayar K, Aksu G, Ak I, and Tosun M (2003) Venlafaxine treatment of fibromyalgia. Ann Pharmacother 37:1561-1565.
28. Schober CE and Ansani NT (2003) Venlafaxine hydrochloride for the treatment of hot flashes. Ann Pharmacother 37:1703-1707.
29. Sommer C (2004) Serotonin in pain and analgesia: actions in the periphery. Mol Neurobiol 30:117-125.
30. Stahl SM, Grady MM, Moret C, and Briley M (2005) SNRIs: their pharmacology, clinical efficacy and tolerability in comparison with other classes of antidepressants. CNS Spectr 10:732-747.
31. Stearns V, Beebe KL, Iyengar M, and Dube E (2003) Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. J Am Med Assoc 289:2827-2834.
32. Teschemacher AG (2005) Real-time measurements of noradrenaline release in periphery and central nervous system. Autonom Neurosci Basic Clin 117:1-8.
33. Uhl GR and Johnson PS (1994) Neurotransmitter transporters: three important gene families for neuronal function. J Exp Biol 196:229-236.
34. Willis WD and Westlund KN (1997) Neuroanatomy of the pain system and of the pathways that modulate pain. J Clin Neurophysiol 14:2-31.